A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 2)
Clinical trial NCT04897412 · COMPLETED
Trial details
- NCT number
- NCT04897412
- Sponsor
- Caliway Biopharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-14
- Primary completion
- 2023-02-22
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.